• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C CARBON DIOXIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY C CARBON DIOXIDE Back to Search Results
Catalog Number 07P72-20
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
Correction/removal reporting number = 3002809144-10/24/19-009-r the investigation into this matter found that the amount of co2 absorbed was higher with increased reagent carousel rotation and when the volume of the reagent in the cartridge is reduced.This phenomenon could be detected as a shift in qc and also incorrect patient results.A product recall letter was sent to all customers who have received shipments of the impacted lots of the alinity c carbon dioxide reagent kit.The letter instructs the following: immediately discontinue use of the alinity c carbon dioxide 15000t kit and destroy any remaining inventory as existing modes of control are not effective for the large cartridge.Run two levels of co2 controls every hour with the use of the current alinity c carbon dioxide 3000t kit, instead of every 24 hours, and perform assay calibration as needed to minimize the potential to generate incorrect results.All current inventory of alinity c carbon dioxide (ln 07p7220), will be reworked to include a kit stuffer instructing customers to run qc every hour.In future lots of the alinity c carbon dioxide 3000t kit, the reagent cartridge fill volume will be increased from 12.7 ml to 20.7 ml, which has been confirmed to minimize co2 absorption.
 
Event Description
The customer reported imprecision in the quality controls (qc) while using the carbon dioxide (co2) reagent.The customer was instructed to run 3-4 runs of duplicate qcs per day.The customer stated the 3 level qc materials were all tested on the same reagent cartridge with the same calibration curve.There was no reported impact to patient management.
 
Manufacturer Narrative
Complete information for section h9.Correction/removal reporting number = 3002809144-10/24/19-009-r upon further review, the customer's issue is not associated with remedial action 3002809144-10/24/19-009-r and is unassigned from the field action.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C CARBON DIOXIDE
Type of Device
CARBON DIOXIDE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9512911
MDR Text Key219779863
Report Number3002809144-2019-01086
Device Sequence Number1
Product Code KHS
UDI-Device Identifier00380740121594
UDI-Public00380740121594
Combination Product (y/n)N
PMA/PMN Number
K060295
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date 01/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Catalogue Number07P72-20
Device Lot Number55731UQ09
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 12/13/2019
Initial Date FDA Received12/23/2019
Supplement Dates Manufacturer Received01/07/2020
Supplement Dates FDA Received01/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number3002809144-10/24/19-009-
Patient Sequence Number1
Treatment
ALINITY C PROCESSING MODULE; ALINITY C PROCESSING MODULE; LIST 03R67-01, SN (B)(4); LIST 03R67-01, SN (B)(4)
-
-